BASIC—ALIMENTARY TRACT Loss of Adiponectin Promotes Intestinal Carcinogenesis in Min and Wild-type Mice

[1]  H. Nagawa,et al.  Adiponectin suppresses tumorigenesis in Apc(Min)(/+) mice. , 2010, Cancer letters.

[2]  X. Huang,et al.  Obesity, the PI3K/Akt signal pathway and colon cancer , 2009, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[3]  H. Nakagama,et al.  Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition , 2008, Gut.

[4]  T. Sugimura,et al.  Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice. , 2008, Carcinogenesis.

[5]  P. Stattin,et al.  Components of the metabolic syndrome and colorectal cancer risk; a prospective study , 2008, International Journal of Obesity.

[6]  E. Hahn,et al.  Effect of Adiponectin and Ghrelin on Apoptosis of Barrett Adenocarcinoma Cell Line , 2008, Digestive Diseases and Sciences.

[7]  Kohjiro Ueki,et al.  Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. , 2007, Cell metabolism.

[8]  A. Folsom,et al.  The metabolic syndrome and risk of incident colorectal cancer , 2006, Cancer.

[9]  Y. Matsuzawa.  The metabolic syndrome and adipocytokines , 2006, FEBS letters.

[10]  Tadahisa Fukui,et al.  Association of Visceral Fat Accumulation and Plasma Adiponectin with Colorectal Adenoma: Evidence for Participation of Insulin Resistance , 2005, Clinical Cancer Research.

[11]  J. Clark,et al.  Spinal CK2 regulates nociceptive signaling in models of inflammatory pain , 2005, Pain.

[12]  N. Ruderman,et al.  AMPK, the metabolic syndrome and cancer. , 2005, Trends in pharmacological sciences.

[13]  S. Narumiya,et al.  Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development. , 2004, Carcinogenesis.

[14]  S. Narumiya,et al.  Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development , 2004, Gut.

[15]  P. Froguel,et al.  Insulin/Foxo1 Pathway Regulates Expression Levels of Adiponectin Receptors and Adiponectin Sensitivity* , 2004, Journal of Biological Chemistry.

[16]  R. Balsara,et al.  Enhanced in Vitro Proliferation of Aortic Endothelial Cells from Plasminogen Activator Inhibitor-1-deficient Mice* , 2004, Journal of Biological Chemistry.

[17]  E. Giovannucci.  Insulin and colon cancer , 1995, Cancer Causes & Control.

[18]  T. Sugimura,et al.  Dose‐dependent suppression of hyperlipidemia and intestinal polyp formation in Min mice by pioglitazone, a PPARγ ligand , 2003, Cancer science.

[19]  T. Noda,et al.  Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands. , 2003, Cancer research.

[20]  Philippe Froguel,et al.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.

[21]  S. B. Pedersen,et al.  Metformin, but not Thiazolidinediones, Inhibits Plasminogen Activator Inhibitor-1 Production in Human Adipose Tissue in Vitro , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[22]  Philippe Froguel,et al.  Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation* , 2002, The Journal of Biological Chemistry.

[23]  A. Dyer,et al.  Colorectal cancer mortality and factors related to the insulin resistance syndrome. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  M. Trevisan,et al.  Markers of insulin resistance and colorectal cancer mortality. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[25]  Y. Terauchi,et al.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.

[26]  P. Scherer,et al.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action , 2001, Nature Medicine.

[27]  R. Bird,et al.  The effect of chenodeoxycholic acid on the development of aberrant crypt foci in the rat colon. , 1994, Cancer letters.

[28]  P. Vague,et al.  Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin. , 1993, The Journal of clinical investigation.

[29]  C. Harris,et al.  Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro. , 1974, Experimental cell research.